CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection
Open Access
- 1 March 2015
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 32 (2) , 76-83
Abstract
No abstract availableKeywords
Funding Information
- American Society of Transplantation
- National Institutes of Health (P01AI81678)
- National Institutes of Health (T32 AI74490)
This publication has 52 references indexed in Scilit:
- Immunosuppression minimization vs. complete drug withdrawal in liver transplantationJournal of Hepatology, 2013
- CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in miceHepatology, 2013
- Dysfunctional CD39POS regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitisHepatology, 2013
- CD39 and CD73 in immunity and inflammationTrends in Molecular Medicine, 2013
- Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7Circulation, 2013
- Purinergic Signaling during InflammationNew England Journal of Medicine, 2012
- Purinergic P2Y2 Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver InjuryGastroenterology, 2012
- Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/Entpd1 null MiceHepatology, 2012
- Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cellsHepatology, 2012
- Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injuryThrombosis and Haemostasis, 2004